Drug
Fabrazyme
Fabrazyme: highest development phase Phase 2, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fabrazyme (agalsidase beta) NCT00837824 | Phase 2 | Fabry Disease |
Latest
No recent events.
Follow Fabrazyme on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.